Increased IGF-I and decreased adiponectin levels in patients with GDM might have been responsible for enhancing GLUT1 expression via the stimulation of placental insulin/IGF-1 signaling, which might have affected fetal growth [47]. This evidence concerns the gene INS and gestational diabetes.